End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
155,930 CLP | -.--% | -.--% | +14.33% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
JOHNSON & JOHNSON | Other Pharmaceuticals | -.--% | -.--% | +14.33% | -1.30% | - | 352B | - | - | - |
- Stock Market
- Equities
- JNJ Stock
- JNJCL Stock
- Charts Johnson & Johnson
- Relative Strength Chart